Raymond James Financial Services Advisors Inc. lessened its holdings in Danimer Scientific, Inc. (NYSE:DNMR – Get Rating) by 7.5% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 242,300 shares of the company’s stock after selling 19,744 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Danimer Scientific were worth $715,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also added to or reduced their stakes in DNMR. Retirement Planning Co of New England Inc. bought a new stake in Danimer Scientific in the third quarter valued at approximately $40,000. Rinkey Investments purchased a new stake in Danimer Scientific during the 2nd quarter valued at $94,000. Swiss National Bank boosted its position in Danimer Scientific by 12.1% during the 2nd quarter. Swiss National Bank now owns 212,800 shares of the company’s stock valued at $970,000 after buying an additional 23,000 shares during the period. Lehman & Derafelo Financial Resources LLC bought a new stake in Danimer Scientific in the 2nd quarter worth $91,000. Finally, First Heartland Consultants Inc. increased its position in shares of Danimer Scientific by 68.7% in the third quarter. First Heartland Consultants Inc. now owns 21,674 shares of the company’s stock valued at $63,000 after acquiring an additional 8,823 shares during the period. 43.98% of the stock is owned by institutional investors.
Danimer Scientific Stock Up 1.8 %
Shares of Danimer Scientific stock opened at $2.26 on Tuesday. The company has a current ratio of 5.15, a quick ratio of 4.04 and a debt-to-equity ratio of 0.73. Danimer Scientific, Inc. has a 12-month low of $1.57 and a 12-month high of $6.78. The company has a market cap of $229.14 million, a P/E ratio of -1.40 and a beta of 1.37. The company’s fifty day simple moving average is $2.12 and its two-hundred day simple moving average is $3.20.
Analysts Set New Price Targets
A number of research firms have recently weighed in on DNMR. Piper Sandler started coverage on shares of Danimer Scientific in a report on Wednesday, October 12th. They set an “overweight” rating and a $4.50 target price for the company. Cowen dropped their price objective on Danimer Scientific to $4.00 in a report on Tuesday, November 15th.
Insiders Place Their Bets
In other news, CMO Scott Tuten sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 17th. The stock was sold at an average price of $2.68, for a total value of $26,800.00. Following the completion of the transaction, the chief marketing officer now owns 434,136 shares in the company, valued at approximately $1,163,484.48. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In the last quarter, insiders have sold 30,000 shares of company stock worth $64,500. Company insiders own 14.60% of the company’s stock.
Danimer Scientific Profile
Danimer Scientific, Inc, a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.
- Get a free copy of the StockNews.com research report on Danimer Scientific (DNMR)
- Is the Northrop Grumman Selloff an Opportunity?
- Is the Worst Behind for Under Armor Stock with a New CEO?
- Analysts Like The Fit Of Skechers USA
- What Does Microsoft’s Investment in ChatGBT Mean for MSFT Stock?
- Can We Trust The Rally In The S&P 500
Receive News & Ratings for Danimer Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danimer Scientific and related companies with MarketBeat.com's FREE daily email newsletter.